FRUQUINTINIB
fruquintinib 5 mg capsule, 21
FRUQUINTINIB (15344N)
15344N
Manner of administration:Oral
Restriction 18516
Indication: Metastatic colorectal cancer
Treatment phase: Initial PBS-subsidised treatment
Restriction 18520
Indication: Metastatic colorectal cancer
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 5 | DPMQ: $6,757.93 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Fruzaqla | |||||